Bronchiolar disorders
JH Ryu, JL Myers, SJ Swensen - American journal of respiratory …, 2003 - atsjournals.org
Bronchiolar abnormalities are relatively common and occur in a variety of clinical settings.
Various histopathologic patterns of bronchiolar injury have been described and have led to …
Various histopathologic patterns of bronchiolar injury have been described and have led to …
Respiratory syncytial virus bronchiolitis.
AKC Leung, JD Kellner, HD Davies - Journal of the National …, 2005 - ncbi.nlm.nih.gov
Respiratory syncytial virus, the most common cause of bronchiolitis, is the leading cause of
infant hospitalization in developed countries and accounts for substantial mortality and …
infant hospitalization in developed countries and accounts for substantial mortality and …
Study of montelukast for the treatment of respiratory symptoms of post–respiratory syncytial virus bronchiolitis in children
H Bisgaard, A Flores-Nunez, A Goh… - American journal of …, 2008 - atsjournals.org
Rationale: A pilot study (Bisgaard H; Study Group on Montelukast and Respiratory Syncytial
Virus. A randomized trial of montelukast in respiratory syncytial virus postbronchiolitis. Am J …
Virus. A randomized trial of montelukast in respiratory syncytial virus postbronchiolitis. Am J …
Deletion of TLR3 alters the pulmonary immune environment and mucus production during respiratory syncytial virus infection
BD Rudd, JJ Smit, RA Flavell… - The Journal of …, 2006 - journals.aai.org
The detection of a viral infection by pattern recognition receptors (PAMPs) is an integral part
of antiviral immunity. In these studies we have investigated the role of TLR3, which …
of antiviral immunity. In these studies we have investigated the role of TLR3, which …
Differential immune responses and pulmonary pathophysiology are induced by two different strains of respiratory syncytial virus
In this study we performed comparisons of pulmonary responses between two different
respiratory syncytial virus (RSV) antigenic subgroup A strains, A2 and Line 19. Line 19 strain …
respiratory syncytial virus (RSV) antigenic subgroup A strains, A2 and Line 19. Line 19 strain …
Therapeutic monoclonal antibody treatment targeting respiratory syncytial virus (RSV) G protein mediates viral clearance and reduces the pathogenesis of RSV …
LM Haynes, H Caidi, GU Radu, C Miao… - Journal of Infectious …, 2009 - academic.oup.com
Because the G protein of respiratory syncytial virus (RSV) has a CX3C chemokine motif that
has been associated with the ability of RSV G protein to modulate the virus-induced host …
has been associated with the ability of RSV G protein to modulate the virus-induced host …
Infant exposure to fine particulate matter and traffic and risk of hospitalization for RSV bronchiolitis in a region with lower ambient air pollution
Few studies investigate the impact of air pollution on the leading cause of infant morbidity,
acute bronchiolitis. We investigated the influence of PM2. 5 and other metrics of traffic …
acute bronchiolitis. We investigated the influence of PM2. 5 and other metrics of traffic …
[HTML][HTML] Risk factors for severe bronchiolitis caused by respiratory virus infections among Mexican children in an emergency department
M Robledo-Aceves, M de Jesús Moreno-Peregrina… - Medicine, 2018 - journals.lww.com
Severe bronchiolitis is the most common reason for hospitalization among children younger
than 2 years. This study analyzed the prevalence of community-acquired respiratory virus …
than 2 years. This study analyzed the prevalence of community-acquired respiratory virus …
Infectious Disease Morbidity Among Young HIV-1–Exposed But Uninfected Infants in Latin American and Caribbean Countries: The National Institute of Child Health …
MM Mussi-Pinhata, L Freimanis, AY Yamamoto… - …, 2007 - publications.aap.org
OBJECTIVE. The goal was to describe the frequency, characteristics, and correlates of
infectious disease morbidity during the first 6 months of life among HIV-1–exposed but …
infectious disease morbidity during the first 6 months of life among HIV-1–exposed but …
The G glycoprotein of respiratory syncytial virus depresses respiratory rates through the CX3C motif and substance P
Respiratory syncytial virus (RSV) infection in the neonate can alter respiratory rates, ie, lead
to episodes of apnea. We show that RSV G glycoprotein reduces respiratory rates …
to episodes of apnea. We show that RSV G glycoprotein reduces respiratory rates …